Park Avenue Securities’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,459
Closed -$208K 1365
2024
Q1
$208K Buy
+2,459
New +$195K ﹤0.01% 1317
2023
Q4
Sell
-3,741
Closed -$259K 1340
2023
Q3
$259K Buy
+3,741
New +$267K ﹤0.01% 1118
2023
Q1
Sell
-4,921
Closed -$367K 793
2022
Q4
$367K Buy
4,921
+350
+8% +$25.1K 0.01% 894
2022
Q3
$300K Sell
4,571
-444
-9% -$34K 0.01% 906
2022
Q2
$353K Buy
5,015
+478
+11% +$38.5K 0.01% 843
2022
Q1
$417K Buy
4,537
+479
+12% +$45K 0.01% 819
2021
Q4
$411K Buy
4,058
+468
+13% +$47.7K 0.01% 793
2021
Q3
$349K Buy
3,590
+234
+7% +$23.6K 0.01% 803
2021
Q2
$346K Buy
3,356
+400
+14% +$40.7K 0.01% 780
2021
Q1
$263K Buy
+2,956
New +$273K 0.01% 829

Other funds holding CRI

Park Avenue Securities's CRI Position: Q2 2024 in Review

Park Avenue Securities sold out of Carter's (CRI) in Q2 2024, closing a stake of 2,459 shares — an estimated $208K sold.

Park Avenue Securities first reported a position in CRI in Q1 2021 and held it in 10 quarters. The position peaked at $417K in Q1 2022. 329 funds tracked by Wall St. Rank hold CRI as of Q2 2024.

  • Park Avenue Securities reported no remaining Carter's position as of Q2 2024 after selling out during the quarter.
  • Park Avenue Securities sold 2,459 Carter's shares in Q2 2024, an estimated $208K.
  • Park Avenue Securities first reported a position in Carter's in Q1 2021 and held it in 10 quarters.
  • Park Avenue Securities's Carter's position peaked at $417K in Q1 2022.
  • 329 funds tracked by Wall St. Rank held Carter's as of Q2 2024.

Based on Park Avenue Securities's 13F filing for Q2 2024, filed 9 Jul 2024.